AXSOME THERAPEUTICS INC. - COMMON STOCK
121,91
14-марта-25 15:45:00
15 мин. задержка
Акции
+0,26
+0,21%
Сегодняшний диапазон
120,52 - 123,47
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
27 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
22 фев 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
07 фев 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
31 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
07 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
28 ноя 2022 05:35:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
23 ноя 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
09 ноя 2022 06:00:02 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
07 ноя 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
27 окт 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022
21 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
20 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
10 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
03 окт 2022 05:30:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
29 сен 2022 06:28:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
21 сен 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
14 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Initiates ADVANCE-2 Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
08 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire